Publicaciones en colaboración con investigadores/as de Universidad de Salamanca (8)

2010

  1. In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma

    Haematologica, Vol. 95, Núm. 5, pp. 794-803

2009

  1. DNA DSBs Induction by Zalypsis, a Novel Marine Compound, Results in Potent Antimyeloma Activity

    CLINICAL LYMPHOMA & MYELOMA

  2. Zalypsis: A novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks

    Blood, Vol. 113, Núm. 16, pp. 3781-3791

2007

  1. EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model

    Journal of Molecular Medicine, Vol. 85, Núm. 9, pp. 1015-1029

  2. Pseudomesotheliomatous carcinoma of the lung with a distinct morphology, immunohistochemistry, and comparative genomic hybridization profile

    Annals of Diagnostic Pathology, Vol. 11, Núm. 4, pp. 241-251

2005

  1. Gene expression profile of Ewing sarcoma cell lines differing in their EWS-FLI1 fusion type

    Journal of Pediatric Hematology/Oncology, Vol. 27, Núm. 10, pp. 537-542

  2. Insuficiencia respiratoria neonatal asociada a mutación en el gen de la proteína C del surfactante

    Anales de Pediatria, Vol. 62, Núm. 3, pp. 210-214

2004

  1. Imatinib Inhibits Proliferation of Ewing Tumor Cells Mediated by the Stem Cell Factor/KIT Receptor Pathway, and Sensitizes Cells to Vincristine and Doxorubicin-Induced Apoptosis

    Clinical Cancer Research, Vol. 10, Núm. 2, pp. 751-761